John Lothian News interviewed Michael Riddle, CEO of Eris Innovations, and Agha Mirza, managing director and global head of rates and OTC products for the CME Group about the success of the Eris SOFR products trading on the CME.
JLN asked about the origin story of the Eris products and when they began to trade on the CME.
We asked about the recent events that have driven the growth of the products. We asked about the impact of the regional banking crisis on the products.
Riddle and Mirza also discussed who the users of the products are and what plans Eris Innovations has to extend the product mix in the next three to five years.
Tim Babcock, the vice president and head of the TSX Venture Exchange, was recently interviewed by John Lothian News about TSX's Venture Forward initiative,...
The coronavirus has had a profound impact on all market sectors, including botannicals. In the latest John Lothian News report on canna business, the...
John Lothian News is presenting the May 14 Bachelier Options Model virtual panel as a podcast. We have edited the content down to maximize...
